VANCOUVER, Washington, Feb. 08, 2019 — CytoDyn Inc. (otc.qb:CYDY), CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that it will be presenting a company overview at BIO […]
VANCOUVER, Washington, Feb 01, 2019 — Successful interim results in the 700 mg monotherapy arm prompted the FDA to allow CytoDyn to switch all remaining combination therapy patients from CD02-Extension study from 350 mg to […]
PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) FSD Pharma Inc. (“FSD Pharma”)(OTC: FSDDF) and Solarvest BioEnergy Inc. (SVS) (“Solarvest”) ()Parties”), a technology company which has developed an algal-based flexible production platform […]
TORONTO, Jan. 18, 2019 – Cobalt 27 Capital Corp. (“Cobalt 27” or the “Company”) (TSXV: KBLT)(OTCQX: CBLLF)(FRA: 27O), a battery metals streaming and royalty company offering direct exposure to metals integral to electric vehicles and energy storage systems, today announced […]
Today MedPharm Holdings announced the successful formulation and development of micro-emulsified, cannabis infused, dissolvable thin strips “Melts,” powered with their proprietary Lipophilic Enhanced Absorption Formulation (LEAF) technology. The oral strip is unique in that it […]
DENVER – January 17, 2019 – Today Medicine Man Technologies (OTCQX: MDCL), a leading consulting, intellectual property licensing and products company in the cannabis industry, has announced a binding agreement that is expected to lead […]
Medicine Man Technologies Adds Marijuana Research Company, Branded Product Lines and Intellectual Property Development Capabilities to Their International Base of Over 100 Clients DENVER, CO/ January 15, 2019 / Medicine Man Technologies (OTCQX: MDCL), a leading […]
Company in position for pre-sales license inspection, last step to issuance of a Sales License FSD Pharma Inc. (“FSD Pharma” or the “Company”) (OTC: FSDDF) (cse:HUGE)(fra:0K9) is pleased to announce that its wholly-owned subsidiary, FV […]
BLA update and major licensing initiatives in cancer and immunology VANCOUVER, Washington, Jan 08, 2019- CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that […]
CELLCUBE ENERGY STORAGE SYSTEMS INC. – Toronto, Ontario, Jan 04, 2019 (cse:CUBE) (otcqb:CECBF) (01X) (wkn:A2JMGP) (the “Company”) dated January 2, 2019, the Company confirms that the Canadian Stock Exchange (“CSE”) bulletin dated January 2, 2019 is […]
Beckerman will represent Elixinol’s position in hemp industry’s dynamic U.S. regulatory and advocacy environment DENVER , Jan 03, 2019 — Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (asx:EXL) announces Joy Beckerman’s appointment to Elixinol’s […]
TORONTO–December 21, 2018-FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, […]
Companies Anticipate Another Precedential Ruling from the Federal Circuit Three Judge Panel Based on One Over-Arching Argument LOS ANGELES, CA / ACCESSWIRE / December 19, 2018 / Decision Diagnostics Corp. (otc pink:DECN) Decision Diagnostics Corp. […]
DENVER, Dec. 11, 2018 — US-based Elixinol (OTC: ELLXF) announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. The 8 hemp-based products include cleansers, moisturizers, serums, shampoo, […]
SYDNEY, Dec. 20, 2018 — Elixinol Global Limited (EXL, Group or the Company) (ASX: EXL; OTCQX: ELLXF), a global company operating in the hemp, dietary supplements and emerging medicinal cannabis sectors, is delighted to announce that the President of […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
